Millendo Therapeutics, Inc.
(NASDAQ GS: MLND)
Rigrodsky Law, P.A. is investigating Millendo Therapeutics, Inc. (“Millendo”) regarding possible breaches of fiduciary duties and other violations of law related to Millendo’s agreement to merge with Tempest Therapeutics, Inc.